Article Information
History
- January 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David M. Smadja1,2,*,
- Christophe Peronino1,2,3,
- Léa Jilet3,
- Peter Ivak4,5,
- Yuri Pya6,
- Aurélien Philippe1,2,
- Christian Latremouille3,
- Finn Gustafsson7,
- Faiz Z. Ramjankhan8,
- Jean Christian Roussel9,
- André Vincentelli10,
- Erwan Flecher11,
- Pascale Gaussem1,2,
- Piet Jansen3 and
- Ivan Netuka4
- 1Université de Paris-Cité, Innovative Therapies in Hemostasis, INSERM, F-75006 Paris, France
- 2Hematology department and Biosurgical Research lab (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015 Paris, France
- 3Carmat SA, Velizy-Villacoublay, France
- 4Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 5Department of Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 6National Research Cardiac Surgery Center, Nur-Sultan, Kazakhstan
- 7Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark
- 8University Medical Center Utrecht, Utrecht, the Netherlands
- 9Cardiac and thoracic Surgery Department, CHU de Nantes, hôpital Nord Laënnec, boulevard Jacques-Monod, Saint-Herblain, 44093 Nantes cedex 1, France
- 10Univ. Lille, CHU Lille, Department of Cardiac Surgery, F-59000 Lille, France
- 11Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France
- ↵*Corresponding author:
Professor David M. Smadja. Georges Pompidou European Hospital, Hematology department, 20 rue Leblanc, F-75015, Paris, France. Email: david.smadja{at}aphp.fr
Posted January 20, 2023.
Platelet activation with the Aeson Bioprosthetic Total Artificial Heart: insight from aspirin treatment and outcomes
